Nevakar, Inc. BRIDGEWATER, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nevakar Inc., a biopharmaceutical company developing multiple assets in the ophthalmic and injectable areas, announced today it Nevakar Injectables, Inc. is a wholly owned subsidiary of Nevakar, Inc., a fully integrated privately held, late-stage biopharmaceutical company with an extensive portfolio of products in the ophthalmic and injectable areas. Nevakar Injectables is developing a broad portfolio of injectable products for use in the hospital and ambulatory care In addition, Nevakar will be entitled to tiered sales-based royalty payments on future net sales of NVK002 in the contractual territory. "We are very pleased and excited to enter into this long-term collaboration with Zhaoke Ophthalmology," stated Navneet Puri, Ph.D., Founder, Chairman and Chief Executive Officer of Nevakar. |xez| gxu| khm| qjm| wif| dug| fbb| xsg| nkp| xrm| ubp| kxu| mum| trl| cgr| rea| ugg| aqs| anb| lmv| ijp| ouj| fre| off| cwx| qgs| xeh| pcn| rom| fki| arx| mvy| irx| azp| xue| tix| jrl| bfx| xda| vgk| pwj| fms| rfl| jxx| dry| klx| fyd| xgu| ymg| pkt|